Embryonic stem cell-derived glial precursors: A source of myelinating transplants

Science

Volumn 285, Issue 5428, 1999, Pages 754-756

  Brüstle, Oliver ^a   Jones, Kimberly N ^a,b   Learish, Randall D ^c,d   Karram, Khalad ^a   Choudhary, Khalid ^a,b   Wiestler, Otmar D ^a   Duncan, Ian D ^c   McKay, Ronald D G ^b  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d PROMEGA CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEOLIPID PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL SURVIVAL; EMBRYO; EMBRYO CELL; GLIA CELL; HISTOCHEMISTRY; MALE; MOUSE; MYELINATION; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PELIZAEUS MERZBACHER DISEASE; PRIORITY JOURNAL; STEM CELL; STEM CELL TRANSPLANTATION;

ANIMALS; ASTROCYTES; BRAIN; CELL DIFFERENTIATION; CELL LINE; CELL MOVEMENT; CEREBRAL VENTRICLES; DIFFUSE CEREBRAL SCLEROSIS OF SCHILDER; EMBRYO; GROWTH SUBSTANCES; HUMANS; MALE; MICE; MYELIN BASIC PROTEINS; MYELIN PROTEOLIPID PROTEIN; MYELIN SHEATH; OLIGODENDROGLIA; RATS; SPINAL CORD; STEM CELL TRANSPLANTATION; STEM CELLS;

ANIMALIA;

EID: 0033618593     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.285.5428.754     Document Type: Article

References (39)

1. M. J. Evans and M. H. Kaufman, Nature 292, 154 (1981); G. R. Martin, Proc. Natl. Acad. Sci. U.S.A. 78, 7634 (1981).
2. M. J. Evans and M. H. Kaufman, Nature 292, 154 (1981); G. R. Martin, Proc. Natl. Acad. Sci. U.S.A. 78, 7634 (1981).
3. J. A. Thomson et al., Science 282, 1145 (1998); M. J. Shamblott et al., Proc. Natl. Acad. Sci U.S.A. 95, 13726 (1998).
4. J. A. Thomson et al., Science 282, 1145 (1998); M. J. Shamblott et al., Proc. Natl. Acad. Sci U.S.A. 95, 13726 (1998).
5. I. Wilmut, A. E. Schnieke, J. McWhir, A. J. Kind, K. H. S. Campbell, Nature 385, 810 (1997); T. Wakayama, A. C. Perry, M. Zuccotti, K. R. Johnson, R. Yanagimachi, ibid. 394, 369 (1998).
6. I. Wilmut, A. E. Schnieke, J. McWhir, A. J. Kind, K. H. S. Campbell, Nature 385, 810 (1997); T. Wakayama, A. C. Perry, M. Zuccotti, K. R. Johnson, R. Yanagimachi, ibid. 394, 369 (1998).
7. G. Keller, Curr. Opin. Cell Biol. 7, 862 (1995); G. Bain, D. Kitchens, M. Yao, J. E. Huettner, D. I. Gottlieb, Dev. Biol. 168, 342 (1995); A. Fraichard et al., J. Cell Sci. 108, 3181 (1995); M. F. A. Finley, N. Kulkami, J. E. Huettner, J. Neurosci. 16, 1056 (1996); M. Li, L. Pevny, R. Lovell-Badge, A. Smith, Curr. Biol. 8, 971 (1998).
8. G. Keller, Curr. Opin. Cell Biol. 7, 862 (1995); G. Bain, D. Kitchens, M. Yao, J. E. Huettner, D. I. Gottlieb, Dev. Biol. 168, 342 (1995); A. Fraichard et al., J. Cell Sci. 108, 3181 (1995); M. F. A. Finley, N. Kulkami, J. E. Huettner, J. Neurosci. 16, 1056 (1996); M. Li, L. Pevny, R. Lovell-Badge, A. Smith, Curr. Biol. 8, 971 (1998).
9. G. Keller, Curr. Opin. Cell Biol. 7, 862 (1995); G. Bain, D. Kitchens, M. Yao, J. E. Huettner, D. I. Gottlieb, Dev. Biol. 168, 342 (1995); A. Fraichard et al., J. Cell Sci. 108, 3181 (1995); M. F. A. Finley, N. Kulkami, J. E. Huettner, J. Neurosci. 16, 1056 (1996); M. Li, L. Pevny, R. Lovell-Badge, A. Smith, Curr. Biol. 8, 971 (1998).
10. G. Keller, Curr. Opin. Cell Biol. 7, 862 (1995); G. Bain, D. Kitchens, M. Yao, J. E. Huettner, D. I. Gottlieb, Dev. Biol. 168, 342 (1995); A. Fraichard et al., J. Cell Sci. 108, 3181 (1995); M. F. A. Finley, N. Kulkami, J. E. Huettner, J. Neurosci. 16, 1056 (1996); M. Li, L. Pevny, R. Lovell-Badge, A. Smith, Curr. Biol. 8, 971 (1998).
11. G. Keller, Curr. Opin. Cell Biol. 7, 862 (1995); G. Bain, D. Kitchens, M. Yao, J. E. Huettner, D. I. Gottlieb, Dev. Biol. 168, 342 (1995); A. Fraichard et al., J. Cell Sci. 108, 3181 (1995); M. F. A. Finley, N. Kulkami, J. E. Huettner, J. Neurosci. 16, 1056 (1996); M. Li, L. Pevny, R. Lovell-Badge, A. Smith, Curr. Biol. 8, 971 (1998).
12. R. McKay, Science 276, 66 (1997); O. Bögler, D. Wren, S. C. Barnett, H. Land, M. Noble, Proc. Natl. Acad. Sci. U.S.A. 87, 6368 (1990).
13. R. McKay, Science 276, 66 (1997); O. Bögler, D. Wren, S. C. Barnett, H. Land, M. Noble, Proc. Natl. Acad. Sci. U.S.A. 87, 6368 (1990).
14. A. K. Groves et al., Nature 362, 453 (1993); W. F. Blakemore, N. J. Olby, R. J. M. Franklin, Brain Pathol. 5, 443 (1995); F. Lachapelle, ibid., p. 289; I. D. Duncan, W. E. Grever, S. C. Zhang, Mol. Med. Today 3, 554 (1997).
15. A. K. Groves et al., Nature 362, 453 (1993); W. F. Blakemore, N. J. Olby, R. J. M. Franklin, Brain Pathol. 5, 443 (1995); F. Lachapelle, ibid., p. 289; I. D. Duncan, W. E. Grever, S. C. Zhang, Mol. Med. Today 3, 554 (1997).
16. A. K. Groves et al., Nature 362, 453 (1993); W. F. Blakemore, N. J. Olby, R. J. M. Franklin, Brain Pathol. 5, 443 (1995); F. Lachapelle, ibid., p. 289; I. D. Duncan, W. E. Grever, S. C. Zhang, Mol. Med. Today 3, 554 (1997).
17. A. K. Groves et al., Nature 362, 453 (1993); W. F. Blakemore, N. J. Olby, R. J. M. Franklin, Brain Pathol. 5, 443 (1995); F. Lachapelle, ibid., p. 289; I. D. Duncan, W. E. Grever, S. C. Zhang, Mol. Med. Today 3, 554 (1997).
18. ES cells [line J1 (21), passage number ≤ 17] were grown on γ-irradiated embryonic fibroblasts in Dulbecco's modified Eagle's medium (DMEM) containing 20% fetal bovine serum, 0.1 mM 2-mercaptoethanol, nucleosides, nonessential amino acids, and human recombinant leukemia inhibitory factor (LIF, Life Technologies; 1000 units/ml). Cells were passaged once onto gelatin-coated dishes and then aggregated to form embryoid bodies in the absence of LIF. We plated 4-day-old embryoid bodies in tissue culture dishes and propagated them for 5 days in ITSFn medium [DMEM/F12 supplemented with 5 μg/ml insulin, 50 μg/ml transferrin, 30 nM selenium chloride, and 5 μg/ml fibronectin (8)]. Cells were then trypsinized, plated in polyomithine-coated dishes (15 μg/ml), and propagated in DMEM/F12 supplemented with insulin (25 μg/ml), transferrin (50 μg/ml), progesterone (20 nM), putrescine (100 μM), selenium chloride (30 nM) plus FGF2 (10 ng/ml), and laminin (1 μg/ml). After 5 days, cells were harvested by scraping in calcium- and magnesium-free Hanks' buffered salt solution (CMF-HBSS). triturated to a single-cell suspension, replated at a 1:5 ratio, and grown to subconfluency in the presence of FGF2 (10 ng/ml) and ECF (20 ng/ml). Cells were then passaged at a 1:5 ratio and again grown to subconfluency in the presence of FGF2 (10 ng/ml) and PDGF-AA (10 ng/ml). Human recombinant FGF2, EGF, and PDGF-AA (R&D Systems, Minneapolis, MN) were added daily and the medium was replaced every 2 days. In vitro differentiation was induced by growth factor withdrawal.
19. S. Okabe, K. Forsberg-Nilsson, A. C. Spiro, M. Segal, R. D. C. McKay, Mech. Dev. 59, 89 (1996).
20. M. C. Raff, R. H. Miller, M. Noble, Nature 303, 390 (1983).
21. Astrocytic and oligodendroglial differentiation were assessed by immunofluorescence analysis using antibodies to A2B5 (Boehringer; 1:200), O4 (Boehringer; 1:5) and GFAP (ICN; 1:100). Similar results were obtained using the ES cell line CJ7 (22) (passage number ≤ 18). Four days after growth factor withdrawal, 31.4 ± 3.6% and 35.0 ± 7.4% of the cells were immunoreactive to the O4 and GFAP antibodies, respectively (n = 5).
22. I. Sommer and M. Schachner, Dev. Biol. 83, 311 (1981).
23. O. Brüstle and K. Karram, data not shown.
24. Cells growing in medium containing FGF2 and PDGF were harvested and triturated to a single-cell suspension. Spinal cord transplants were performed as described (23). Following laminectomy at the thoracolumbar transition, 100,000 cells in a volume of 1 μl CMF-HBSS were injected into the dorsal column of 7-day-old md rats at one or several levels. The recipient animals received dally i.p. injections of cydosporin (10 mg/kg body weight). All procedures were done in accordance with institutional guidelines.
25. M. E. Hodes, V. M. Pratt, S. R. Dlouhy, Dev. Neurosci. 15, 383 (1993).
26. Transplant recipients were perfusion-fixed with 4% paraformaldehyde at 3 weeks of age. Brains and spinal cords were processed for vibratome sectioning. Selected spinal cord transplant recipients were processed for semi- and ultrathin sectioning by routine procedures. Primary antibodies used for immunohistochemistry were anti-PLP (1:500), anti-MBP (Boehringer; 1:200), anti-CNP (Sigma; 1:200), and anti-GFAP (ICN; 1:100). Antigens were visualized using appropriate peroxidase-conjugated secondary antibodies. Identification of donor cells by DNA in situ hybridization with a probe to mouse satellite DNA was done as described (16).
27. O. Brüstle, U. Maskos, R. D. G. McKay, Neuron 15, 1275 (1995); O. Brüstle et al., Nature Biotechnol. 16, 1040 (1998).
28. O. Brüstle, U. Maskos, R. D. G. McKay, Neuron 15, 1275 (1995); O. Brüstle et al., Nature Biotechnol. 16, 1040 (1998).
29. G. Fishell, Development 121, 803 (1995); K. Campbell, M. Olsson, A. Björklund, Neuron 15, 1259 (1995).
30. G. Fishell, Development 121, 803 (1995); K. Campbell, M. Olsson, A. Björklund, Neuron 15, 1259 (1995).
31. 5 cells in a volume of 4 to 9 μl were injected into the ventricle of E17 rat embryos as described (16).
32. A. G. Smith et al., Nature 336, 688 (1988).
33. O. Brüstle et al., Proc. Natl. Acad. Sci. U.S.A. 94, 14809 (1997); J. Dinsmore et al., Cell Transplant. 5, 131 (1996); T. Deacon, J. Dinsmore, L. C. Costantini, J. Ratliff, O. Isacson, Exp. Neurol. 149, 28 (1998).
34. O. Brüstle et al., Proc. Natl. Acad. Sci. U.S.A. 94, 14809 (1997); J. Dinsmore et al., Cell Transplant. 5, 131 (1996); T. Deacon, J. Dinsmore, L. C. Costantini, J. Ratliff, O. Isacson, Exp. Neurol. 149, 28 (1998).
35. O. Brüstle et al., Proc. Natl. Acad. Sci. U.S.A. 94, 14809 (1997); J. Dinsmore et al., Cell Transplant. 5, 131 (1996); T. Deacon, J. Dinsmore, L. C. Costantini, J. Ratliff, O. Isacson, Exp. Neurol. 149, 28 (1998).
36. E. Li, T. H. Bestor, R. Jaenisch, Cell 69, 915 (1992).
37. P. J. Swiatek and T. Gridley, Genes Dev. 7, 2071 (1993).
38. J. P. Hammang, D. R. Archer, I. D. Duncan, Exp. Neurol. 147, 84 (1997).
39. We thank I. Griffiths for the PLP antibody and R. Buschwald for excellent technical assistance. This work was supported by a Junior Research Award from the state of Nordrhein-Westfalen (O.B.), the BONFOR program (O.B.), and NIH grant NS33710 (I.D.D.).